Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Vile

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
The Journal of Gene Medicine|April 8, 2006
Generation of cell hybrids via a fusogenic cell lineSiew Chiat Cheong, Isabelle Blangenois, Jean-Denis Franssen, et al.
Research Square|April 1, 2025
Immunodominant antiviral T cell responses outcompete immuno-subdominant antitumor responses to reduce the efficacy of oncolytic viroimmunotherapyRichard Vile, Benjamin Kendall, Olivia Liseth, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunityFiona Errington, Lynette Steele, Robin Prestwich, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2014
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, et al.
BMC Cancer|June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancerLucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Bioresearch Open Access|March 22, 2013
Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemiaKathryn Hall, Karen J Scott, Ailsa Rose, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
The Journal of Gene Medicine|April 8, 2006
Generation of cell hybrids via a fusogenic cell lineSiew Chiat Cheong, Isabelle Blangenois, Jean-Denis Franssen, et al.
Research Square|April 1, 2025
Immunodominant antiviral T cell responses outcompete immuno-subdominant antitumor responses to reduce the efficacy of oncolytic viroimmunotherapyRichard Vile, Benjamin Kendall, Olivia Liseth, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunityFiona Errington, Lynette Steele, Robin Prestwich, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2014
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, et al.
BMC Cancer|June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancerLucy Heinemann, Guy R Simpson, Angela Boxall, et al.
Bioresearch Open Access|March 22, 2013
Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemiaKathryn Hall, Karen J Scott, Ailsa Rose, et al.
Pageof 10